These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hematopoiesis in the dog in experiments with acute blood loss replaced by a PFC emulsion combined with polyglucin]. Fedorov NA; Gusenova FM; Afonin NI; Akhsianov UU; Kontuganov NN Patol Fiziol Eksp Ter; 1984; (5):3-7. PubMed ID: 6083530 [No Abstract] [Full Text] [Related]
3. [Dynamics of arterial pressure and gas exchange in dogs with acute blood loss replaced by an emulsion of carbon tetrafluoride]. Akhsianov UU; Afonin NI; Troitskiĭ VB Gematol Transfuziol; 1983 Apr; 28(4):41-4. PubMed ID: 6852512 [No Abstract] [Full Text] [Related]
4. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
5. Clinical experience with Fluosol-DA (20%) in the United States. Tremper KK; Levine EM; Waxman K Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514 [No Abstract] [Full Text] [Related]
6. [Microcirculatory indices in the experimental therapy of acute blood loss using a blood substitute--an oxygen carrier based on perfluorodecalin]. Matvienko VP; Gusenova FM; Afonin NI; Aprosin IuD; Sidliarov DP Gematol Transfuziol; 1983 Apr; 28(4):38-41. PubMed ID: 6852511 [No Abstract] [Full Text] [Related]
8. Blood substitutes and oxygen therapeutics: an overview and current status. Jahr JS; Nesargi SB; Lewis K; Johnson C Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737 [TBL] [Abstract][Full Text] [Related]